DEA Begins Rulemaking to Place Five Synthetic Cannabinoids Into Schedule I on Permanent Basis

Oops! Subscribers must be logged in to access this content.

Not A Controlled Substances’ Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the Controlled Substances Module.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson Controlled Substances Module, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

Synthetic Cannabinoids

DEA Begins Rulemaking to Place Five Synthetic Cannabinoids Into Schedule I on Permanent Basis

Staff Writers

March 4, 2012 at 19:00:00 ET

Exactly one year after exercising its temporary scheduling authority, the Drug Enforcement Administration proposed to place five synthetic cannabinoids permanently into Schedule I of the Controlled Substances Act (77 Fed. Reg. 12508; March 1, 2012). The cannabinoids, designated as 1-pentyl-3-(1-naphthoyl)indole (JWH-018), 1-butyl-3-(1-naphthoyl) indole (JWH-073), 1-[2-(4-morpholin... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Controlled Substances’ Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the Controlled Substances Module.

Subscription Benefits

Start Your Free Trial

DEA Begins Rulemaking to Place Five Synthetic Cannabinoids Into Schedule I on Permanent Basis

My Research Folders

THOMPSON CONTROLLED SUBSTANCES

COMPLIANCE EXPERT

DEA RESOURCES

HELP

CONTACT